A detailed history of State Street Corp transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, State Street Corp holds 2,823,817 shares of DAWN stock, worth $35.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,823,817
Previous 2,826,820 0.11%
Holding current value
$35.8 Million
Previous $39 Million 0.98%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$12.72 - $16.03 $38,198 - $48,138
-3,003 Reduced 0.11%
2,823,817 $39.3 Million
Q2 2024

Aug 14, 2024

SELL
$12.03 - $17.69 $818,797 - $1.2 Million
-68,063 Reduced 2.35%
2,826,820 $39 Million
Q1 2024

May 15, 2024

SELL
$13.56 - $17.46 $6.58 Million - $8.47 Million
-485,215 Reduced 14.36%
2,894,883 $47.8 Million
Q4 2023

Feb 14, 2024

BUY
$9.68 - $15.37 $4.3 Million - $6.83 Million
444,179 Added 15.13%
3,380,098 $49.3 Million
Q3 2023

Nov 14, 2023

SELL
$11.22 - $14.86 $4.69 Million - $6.22 Million
-418,407 Reduced 12.47%
2,935,919 $36 Million
Q2 2023

Aug 14, 2023

BUY
$11.74 - $14.47 $12.9 Million - $15.9 Million
1,097,535 Added 48.63%
3,354,326 $40.1 Million
Q1 2023

May 15, 2023

SELL
$12.75 - $23.41 $2.55 Million - $4.68 Million
-199,744 Reduced 8.13%
2,256,791 $30.2 Million
Q4 2022

Feb 14, 2023

BUY
$18.77 - $22.0 $7.79 Million - $9.13 Million
414,797 Added 20.32%
2,456,535 $52.9 Million
Q3 2022

Nov 15, 2022

BUY
$16.44 - $26.57 $27.7 Million - $44.7 Million
1,682,955 Added 469.07%
2,041,738 $40.9 Million
Q2 2022

Aug 15, 2022

BUY
$5.72 - $17.9 $815,483 - $2.55 Million
142,567 Added 65.94%
358,783 $6.42 Million
Q1 2022

May 16, 2022

BUY
$9.12 - $17.47 $243,731 - $466,885
26,725 Added 14.1%
216,216 $2.15 Million
Q4 2021

Feb 14, 2022

BUY
$15.65 - $26.33 $1.02 Million - $1.72 Million
65,459 Added 52.78%
189,491 $3.19 Million
Q3 2021

Nov 15, 2021

BUY
$20.0 - $27.92 $2.48 Million - $3.46 Million
124,032 New
124,032 $2.94 Million

Others Institutions Holding DAWN

About Day One Biopharmaceuticals, Inc.


  • Ticker DAWN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,461,104
  • Market Cap $931M
  • Description
  • Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...
More about DAWN
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.